Filter by:
Caption
Inside Virginia’s Rise to Biopharma Prominence
As the world continues to struggle with drug supply chains and critical shortages, clusters of activity have emerged to move the needle of medication affordability and accessibility.
A Biopharma Moment Decades in the Making
John Newby is the CEO of Virginia Bio, the nonprofit statewide trade association that serves and promotes the life sciences industry in Virginia.
The Investments Behind a Biopharma Hotspot
A lot changed in Virginia’s life sciences industry in the space of about a month last fall. Between Sept. 16 and Oct. 20, biopharmaceutical manufacturing giants Eli Lilly and Company, AstraZeneca, and Merck & Co.
Continuous Improvement
A pharmaceutical manufacturing innovation that came out of a Virginia university is changing the way medicines are made. The Commonwealth’s universities and the rest of its biopharma research community are making sure Virginia is ready to make the medicines of the future.
Enabling Innovation
Would more men try to prevent unintended pregnancies if their choices for contraception went beyond a condom or vasectomy?
Behind the Effort to Bring Drug Manufacturing Back to U.S. Shores
In October 2025, shovels went into the ground in Elkton, marking the start of a $3 billion pharmaceutical expansion project that will add 400,000 square feet to Merck’s existing campus.
The Urgency of Building Healthier Communities
Pam Cheng is executive vice president of global operations and IT and chief sustainability officer at AstraZeneca, which recently announced a new facility in Albemarle County — the company’s first in Virginia.
Michael Shaps Wineworks, Albemarle County
From Grapes and Grain to Glass
Virginia's Surging Craft Beverage Industry Virginia's first brush with alcoholic beverage production came in 1620, when English settler George Thorpe distilled the first batch of corn whiskey in what would become the United States at the Jamestown settlement near Williamsburg.
